Journal profile · Medicine-General Medicine
Health Sciences Review
ISSN 2772-6320 · Elsevier · United Kingdom
Health Sciences Review: fully open access; APC about USD 2,120; review about 144 days (submission to acceptance, publisher); 47 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Health Sciences Review is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Diabetes Treatment and Management, COVID-19 Clinical Research Studies and Acute Ischemic Stroke Management, together about 18.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Health Sciences Review will accept submissions of review articles from across the full range of therapy areas in health sciences. The journal will aim to give insight into the most urgent and important questions facing clinicians globally across the many different fields of health sciences. The journal will welcome articles from all disciplines and articles that look at important interdisciplinary clinical issues.The journal aims to both educate clinicians on important topics and discover new answers to key questions in health and will therefore consider both systematic reviews and topical educational reviews giving up-to-date summaries of key areas. Therefore, the journal will have an educational role and will not accept articles based solely on impact, but on relevance to today's health issues that have an impact on the future, as determined by the editors.The journal receives a high number of submissions and will accept only a limited number of articles finding a balance between therapy areas, science, clinical, public health, and interdisciplinary topics.The articles will be selected based on their impact on urgent issues in health, global issues in health, and also for educational purposes.
From the journal's Aims & Scope
Research area (LetPub): Medicine-General Medicine
Editor-in-chief Jagdish KhubchandaniPublisher website
Editorial board by country: 4 in mainland China (about 24%); most named United States 5, Mainland China 4, Canada 3, Poland 2, India 1 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes Treatment and ManagementMedicine7.1%
- COVID-19 Clinical Research StudiesMedicine5.8%
- Acute Ischemic Stroke ManagementMedicine5.2%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.2%
- Alzheimer's disease research and treatmentsMedicine4.5%
- Innovations in Medical EducationMedicine4.5%
- Academic Writing and PublishingArts and Humanities4.5%
- Publishing and Scholarly CommunicationArts and Humanities4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| General Medicine | Q1 | 148/669 | 77th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 3.6LetPub ·
- CiteScore (publisher)
- 3.6Publisher website ·
- SJR 2026-06
- 0.6LetPub ·
- SNIP 2026-06
- 1.17LetPub ·
- h-index
- 24OpenAlex ·
- i10-index
- 75OpenAlex ·
- 2-year mean citedness
- 4.09OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 274 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 28 | 28 | 537 |
| 2025 | 47 | 47 | 824 |
| 2024 | 58 | 58 | 641 |
| 2023 | 71 | 71 | 288 |
| 2022 | 63 | 63 | 93 |
| 2021 | 7 | 7 | 8 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
144 dayssubmission to acceptance · community reports about 10 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to first decision
- 14 daysPublisher website ·
- First decision after review
- 99 daysPublisher website ·
- Submission to acceptance
- 144 daysPublisher website ·
- Acceptance to publication
- 1 daysPublisher website ·
- Submission to publication (journal-reported)
- about 25 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,120 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,020 / EUR 1,890 / GBP 1,620 / JPY 250,540 | — | — | |
| LetPub | USD 1,900 | Yes | — | |
| Publisher website | USD 2,500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 10,000 words
- Reference style
- Numbered, in order of citation
Article types accepted10, with length limits
- commentariesHealth Sciences Review only accepts review articles along with letters and commentaries.Length not stated
- commentaryHealth Sciences Review only accepts review articles along with letters and commentaries. We are not currently accepting original research articles and any origi…Length not stated
- letterHealth Sciences Review only accepts review articles along with letters and commentaries. We are not currently accepting original research articles and any origi…Length not stated
- lettersHealth Sciences Review only accepts review articles along with letters and commentaries.Length not stated
- original research articleHealth Sciences Review only accepts review articles along with letters and commentaries. We are not currently accepting original research articles and any origi…Length not stated
- perspectiveHealth Sciences Review only accepts review articles along with letters and commentaries. We are not currently accepting original research articles and any origi…Length not stated
- reviewHealth Sciences Review only accepts review articles along with letters and commentaries. We are not currently accepting original research articles and any origi…main text ≤ 10,000 words
- review articleHealth Sciences Review only accepts review articles along with letters and commentaries. We are not currently accepting original research articles and any origi…Length not stated
- scoping reviewScoping Review: The structure is similar to that of a review.Length not stated
- systematic reviewHealth Sciences Review only accepts review articles along with letters and commentaries. We are not currently accepting original research articles and any origi…main text ≤ 10,000 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Publishing ethics policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2772-6320
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Health Sciences Review
How long does peer review take at Health Sciences Review?
The publisher reports about 144 days (submission to acceptance); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Health Sciences Review?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 10,000 words; Reference style: Numbered, in order of citation. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Health Sciences Review based?
Of the 17 board members whose country the journal's board page names, 4 (about 24%) are in mainland China; the countries named most often are United States (5), Mainland China (4) and Canada (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Health Sciences Review?
According to LetPub and DOAJ records, Health Sciences Review is indexed in Scopus and DOAJ.
Is Health Sciences Review open access, and what is the APC?
Health Sciences Review is a fully open-access journal. APC about USD 2,120.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .